治療方案

Elidel®膚樂得®

無類固醇抗濕疹藥膏1

適用於三個月或以上人士及敏感肌膚1,2*

Elidel®膚樂得®（通用名稱：吡美莫司 pimecrolimus）是一種外用鈣調神經磷酸酶抑制劑（TCI, Topical Calcineurin Inhibitor）的抗濕疹藥膏，無類固醇藥膏，適用於所有皮膚區域 (包括面部、頭部、頸部、其他敏感皮膚位置)1,2*

為何選擇Elidel®膚樂得®

• 適合三個月或以上人士及敏感肌膚 1*
• 有效消炎止痕，減低濕疹復發風險 3 
• 同時修復皮膚天然屏障，補充肌膚濕度 4
• 不會使皮膚變薄、萎縮 5

*適用於對其他外用處方類固醇治療沒有充分反應，或不適用的輕度至中度異位性皮膚炎患者 1

歐洲跨學科專家共識指南:

推薦pimecrolimus (Elidel®膚樂得®)為兒童和敏感肌膚輕度至中度異位性皮膚炎的優先選擇。6

美國過敏、哮喘及免疫學學會及學院聯合專家小組異位性皮膚炎（濕疹）指引:7

建議對於 3 個月或以上患有異位性皮膚炎，使用單一保濕產品未能治癒的患者，添加外用鈣調神經磷酸酶抑制劑。7

  • 參考資料PM-COR-24-102904 NOV 2024

    1. Elidel® Cream Prescribing Information: Version September 2022.
    2. Luk D, Hon KLE, Dizon MVC, et al. Practical recommendations for the topical treatment of atopic dermatitis in South and East Asia. Dermatol Ther (Heidelb). 2021;11(1):275-291.
    3. Luger T, De Raeve L, Gelmetti C, et al. Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm. Eur J Dermatol. 2013;23(6):758-766.
    4. Aschoff R, Schwanebeck U, Brautigam M, et al. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis. Exp Dermatol. 2009;18(1):24-29.
    5. Jensen JM, Pfeiffer S, Witt M, et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol. 2009;123(5):1124-1133.
    6. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I. J Eur Acad Dermatol Venereol. 2018;32(5):657-682.
    7. Chu DK, Schneider L, Asiniwasis RN, et al. Atopic Dermatitis (Eczema) Guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE-and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol. 2024; 132:274−312.

相關疾病

過敏症

了解更多 ...